Gold Fields Limited vs Nuwellis Inc — how do they compare? Gold Fields Limited trades at $41.47 (market cap $36.07B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: Gold Fields Limited is far larger — about 66451.7× Nuwellis Inc's market cap, and Gold Fields Limited pays a 5.76% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| GFI | NUWE | |
|---|---|---|
Market Cap | $36.07B | $542.80K |
Sector | Basic Materials | Technology |
52-Week High | $61.52 | $220.50 |
52-Week Low | $29.31 | $1.42 |
Enterprise Value | $37.51B | -$1.27M |
Dividend Yield | 5.76% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →